| Accretion Nutraveda Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar'2025 | Mar'2024 | Mar'2023 | |||
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 0.49 | 0.36 | 0.36 | ||
| Reserves | 4.86 | 0.72 | -0.10 | ||
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | ||
| Equity Application Money | 0.00 | 0.00 | 0.00 | ||
| Total Shareholders Funds | 5.35 | 1.08 | 0.26 | ||
| Secured Loans | 1.93 | 1.42 | 1.30 | ||
| Unsecured Loans | 1.93 | 0.75 | 0.67 | ||
| Total Debt | 3.86 | 2.17 | 1.97 | ||
| Other Liabilities | 0.00 | 0.00 | 0.00 | ||
| Total Liabilities | 9.21 | 3.25 | 2.23 | ||
| APPLICATION OF FUNDS : | |||||
| Gross Block | 3.00 | 2.03 | 1.97 | ||
| Less: Accumulated Depreciation | 0.99 | 0.75 | 0.48 | ||
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | ||
| Net Block | 2.01 | 1.28 | 1.49 | ||
| Lease Adjustments | 0.00 | 0.00 | 0.00 | ||
| Capital Work in Progress | 0.00 | 0.10 | 0.00 | ||
| Investments | 0.00 | 0.00 | 0.00 | ||
| Current Assets, Loans & Advances | |||||
| Inventories | 4.59 | 2.38 | 1.30 | ||
| Sundry Debtors | 3.27 | 0.25 | 0.80 | ||
| Cash and Bank Balance | 0.02 | 0.12 | 0.09 | ||
| Loans and Advances | 0.97 | 0.51 | 0.39 | ||
| Total Current Assets | 8.85 | 3.25 | 2.57 | ||
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 1.06 | 1.27 | 1.80 | ||
| Provisions | 0.56 | 0.10 | 0.00 | ||
| Total CL & Provisions | 1.62 | 1.37 | 1.80 | ||
| Net Current Assets | 7.22 | 1.88 | 0.77 | ||
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | ||
| Deferred Tax Assets | 0.00 | 0.00 | 0.00 | ||
| Deferred Tax Liability | 0.03 | 0.01 | 0.02 | ||
| Net Deferred Tax | -0.03 | -0.01 | -0.02 | ||
| Other Assets | 0.00 | 0.00 | 0.00 | ||
| Total Assets | 9.21 | 3.26 | 2.24 | ||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 |